We then investigated whether the behavioral and molecular changes secondary to hyperglycemia were reversed by insulin treatment in an attempt to identify potential novel therapeutic targets for regulating depressive symptoms in patients with diabetes. This evidence concerns the gene INS and Hyperglycemia.